ATE64298T1 - Verwendung eines mittels mit chemotherapeutische substanz einkapselnden mizellteilchen fuer intravenoeses tumortargeting. - Google Patents

Verwendung eines mittels mit chemotherapeutische substanz einkapselnden mizellteilchen fuer intravenoeses tumortargeting.

Info

Publication number
ATE64298T1
ATE64298T1 AT85113386T AT85113386T ATE64298T1 AT E64298 T1 ATE64298 T1 AT E64298T1 AT 85113386 T AT85113386 T AT 85113386T AT 85113386 T AT85113386 T AT 85113386T AT E64298 T1 ATE64298 T1 AT E64298T1
Authority
AT
Austria
Prior art keywords
micellular
particles
agent
tumor targeting
particles containing
Prior art date
Application number
AT85113386T
Other languages
English (en)
Inventor
Cary Arnett Presant
Richard Thomas Proffitt
Raymond Leo Teplitz
Lawrence Ernest Williams
George Wing-Yiu Tin
Original Assignee
Vestar Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/663,503 external-priority patent/US5435989A/en
Priority claimed from US06/663,550 external-priority patent/US5441745A/en
Application filed by Vestar Inc filed Critical Vestar Inc
Application granted granted Critical
Publication of ATE64298T1 publication Critical patent/ATE64298T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A61K51/1234—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT85113386T 1984-10-22 1985-10-22 Verwendung eines mittels mit chemotherapeutische substanz einkapselnden mizellteilchen fuer intravenoeses tumortargeting. ATE64298T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/663,503 US5435989A (en) 1982-03-30 1984-10-22 Method of targeting a specific location in a body
US06/663,550 US5441745A (en) 1982-03-30 1984-10-22 Method of delivering micellular particles encapsulating chemotherapeutic agents to tumors in a body
EP85113386A EP0179444B1 (de) 1984-10-22 1985-10-22 Verwendung eines Mittels mit chemotherapeutische Substanz einkapselnden Mizellteilchen für intravenöses Tumortargeting

Publications (1)

Publication Number Publication Date
ATE64298T1 true ATE64298T1 (de) 1991-06-15

Family

ID=27098764

Family Applications (1)

Application Number Title Priority Date Filing Date
AT85113386T ATE64298T1 (de) 1984-10-22 1985-10-22 Verwendung eines mittels mit chemotherapeutische substanz einkapselnden mizellteilchen fuer intravenoeses tumortargeting.

Country Status (11)

Country Link
EP (1) EP0179444B1 (de)
JP (1) JPH0747533B2 (de)
KR (1) KR900004802B1 (de)
AT (1) ATE64298T1 (de)
CA (1) CA1298548C (de)
DE (2) DE3583204D1 (de)
DK (2) DK482685D0 (de)
HK (1) HK119993A (de)
IE (1) IE58659B1 (de)
LU (1) LU88811I2 (de)
NL (1) NL960020I1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60901B1 (en) * 1986-08-21 1994-08-24 Vestar Inc Improved treatment of systemic fungal infections with phospholipid particles encapsulating polyene antifungal antibiotics
US5043107A (en) * 1986-08-21 1991-08-27 Vestar Research, Inc. Preparation small unilamellar vesicles including polyene antifungal antibiotics
IL88076A (en) * 1987-10-28 1993-01-14 Nippon Shinyaku Co Ltd Fat emulsions as drug carriers
AU598958B2 (en) 1987-11-12 1990-07-05 Vestar, Inc. Improved amphotericin b liposome preparation
US5648532A (en) * 1993-06-03 1997-07-15 The Regents Of The University Of California Compositions for boron neutron capture therapy and methods thereof
CA2212162A1 (en) * 1995-02-09 1996-08-15 Schering Aktiengesellschaft Liposomes that contain contrast media for the visualization of intravascular space
NO312708B1 (no) * 2000-02-21 2002-06-24 Anticancer Therapeutic Inv Sa Radioaktive liposomer til terapi
WO2005048987A1 (en) * 2003-11-21 2005-06-02 Fuji Photo Film Co., Ltd. Contrast medium comprising liposomes containing hydrophobic chelate compound
EP1745788A1 (de) * 2005-07-22 2007-01-24 KTB Tumorforschungsgesellschaft mbH Acylglycerophospholipide zur Behandlung von Krebs und Tumorkachexie
EP2668961A4 (de) 2010-11-19 2016-07-06 Univ Sapporo Medical Pharmazeutisches kombinationspräparat

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4310505A (en) * 1979-11-08 1982-01-12 California Institute Of Technology Lipid vesicles bearing carbohydrate surfaces as lymphatic directed vehicles for therapeutic and diagnostic substances
JPS59122423A (ja) * 1982-12-28 1984-07-14 Green Cross Corp:The 制癌剤含有脂肪乳剤
JPS59163315A (ja) * 1983-03-09 1984-09-14 Mitsui Pharmaceut Inc カルモフ−ル含有リポソ−ム

Also Published As

Publication number Publication date
IE58659B1 (en) 1993-11-03
LU88811I2 (fr) 1996-11-05
CA1298548C (en) 1992-04-07
HK119993A (en) 1993-11-12
KR860003514A (ko) 1986-05-26
DK484585D0 (da) 1985-10-22
DE3583204D1 (de) 1991-07-18
KR900004802B1 (ko) 1990-07-06
DE19675031I2 (de) 2008-04-10
EP0179444A2 (de) 1986-04-30
DK482685D0 (da) 1985-10-21
JPH0747533B2 (ja) 1995-05-24
NL960020I1 (nl) 1996-11-01
EP0179444B1 (de) 1991-06-12
JPS61158932A (ja) 1986-07-18
IE852602L (en) 1986-04-22
DK167556B1 (da) 1993-11-22
DK484585A (da) 1986-04-23
EP0179444A3 (en) 1987-08-12

Similar Documents

Publication Publication Date Title
US5284831A (en) Drug delivery porphyrin compositions and methods
Proffitt et al. Tumor-imaging potential of liposomes loaded with In-111-NTA: biodistribution in mice
Mitchell et al. Radiosensitization of hematopoietic precursor cells (CFUc) in glioblastoma patients receiving intermittent intravenous infusions of bromodeoxyuridine (BUdR)
Takakura et al. Disposition and tumor localization of mitomycin C–dextran conjugates in mice
Kabalka et al. Gadolinium‐labeled liposomes containing various amphiphilic Gd‐DTPA derivatives: targeted MRI contrast enhancement agents for the liver
US4377567A (en) Lipid membrane drug delivery
Takahashi et al. Attempt at local administration of anticancer agents in the form of fat emulsion
EP2451481B1 (de) Metallnanopartikel, ihre herstellung und verwendung
EP0009842B1 (de) Liposome zur Freigabe von Arzneimitteln und eine ein Arzneimittelsystem mit liposomen enthaltende Bereitung
MY110186A (en) The use of tyloxapol as a nanoparticle stabilizer and dispersant.
DE3583204D1 (de) Verwendung eines mittels mit chemotherapeutische substanz einkapselnden mizellteilchen fuer intravenoeses tumortargeting.
MY109875A (en) Novel formulations for nanoparticulate x-ray blood pool contrast agents using high molecular weight surfactants.
AU4515985A (en) New tetrapyrrole therapeutic agents
CA2153326A1 (en) Taxane formulations comprising phospholipids
ATE121082T1 (de) Tri-azamakrozyklen und deren metall komplexe.
Zimmermann et al. The effect of encapsulation in red blood cells on the distribution of methotrexate in mice
Utley et al. Protection of normal tissues by WR2721 during fractionated irradiation
DE69535094T2 (de) Proteinmarkierung mit radioaktivem phospor und gezielte radiotherapie
KR930700163A (ko) 연조직 종양의 치료 및/또는 진단 방법
CA2393487A1 (en) Pharmaceutical preparation for the treatment of oncoses
ATE70456T1 (de) Verwendung von micellaren partikeln zur herstellung von zusammensetzungen zum beschiessen von tumoren in menschen und deren verwendung.
TRÄGÅRDH et al. Coronary arteriography in canines with calcium-enriched ioxaglate and diatrizoate
EP4558126B1 (de) Injizierbare suspension oder emulsion von beschichteten magnetitnanopartikeln zur verwendung bei der behandlung von soliden tumoren
Chatal et al. Negative liposomes labelled with In 111 oxine in tumor bearing mice
FR2422396A1 (fr) Vehicule compose d'un phospholipide et d'un lipide non miscible, destine a liberer une substance xenobiotique dans l'organisme d'un mammifere